Phase I study of Brequinar sodium (NSC 368390) in patients with solid malignancies.
Schwartsmann G, Dodion P, Vermorken JB, ten Bokkel Huinink WW, Joggi J, Winograd B, Gall H, Simonetti G, van der Vijgh WJ, van Hennik MB, et al.
Schwartsmann G, et al. Among authors: winograd b.
Cancer Chemother Pharmacol. 1990;25(5):345-51. doi: 10.1007/BF00686235.
Cancer Chemother Pharmacol. 1990.
PMID: 2306795